Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,372) Arrow Down
Filter Results: (4,372) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,372)
    • People  (14)
    • News  (1,531)
    • Research  (2,275)
    • Events  (1)
    • Multimedia  (155)
  • Faculty Publications  (1,788)

Show Results For

  • All HBS Web  (4,372)
    • People  (14)
    • News  (1,531)
    • Research  (2,275)
    • Events  (1)
    • Multimedia  (155)
  • Faculty Publications  (1,788)
← Page 49 of 4,372 Results →
  • June 2011 (Revised August 2011)
  • Case

Colgate-Palmolive: Staying Ahead in Oral Care

By: Rebecca M. Henderson and Ryan Johnson
In 2011, Colgate-Palmolive (Colgate) was the global leader in oral care, with a dominant market share lead in toothpaste and a growing presence in toothbrushes and mouthwash. However, the firm faced stiff competition with perennial rivals P&G increasing their focus on... View Details
Keywords: Innovation Strategy; Brands and Branding; Product Positioning; Distribution Channels; Relationships; Competition; Competitive Advantage; Customization and Personalization; Health Industry
Citation
Educators
Purchase
Related
Henderson, Rebecca M., and Ryan Johnson. "Colgate-Palmolive: Staying Ahead in Oral Care." Harvard Business School Case 311-120, June 2011. (Revised August 2011.)
  • January 2019 (Revised June 2019)
  • Technical Note

U.S. Commercial Health Insurance Industry

By: Susanna Gallani, Mary Witkowski and Harry B. Wolberg
This note describes the role of commercial payers in the U.S. healthcare industry. We begin with a review of the historical evolution of commercial payers and their role in the market, from the beginning to the Affordable Care Act and beyond. Every wave of reforms in... View Details
Keywords: Health Care and Treatment; Insurance; Governing Rules, Regulations, and Reforms; Organizational Change and Adaptation; Health Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Gallani, Susanna, Mary Witkowski, and Harry B. Wolberg. "U.S. Commercial Health Insurance Industry." Harvard Business School Technical Note 119-064, January 2019. (Revised June 2019.)
  • 2012
  • Other Unpublished Work

The Instrumental Value of Medical Leadership: Engaging Doctors in Improving Services

By: Richard Bohmer
This paper was commissioned to contribute to The King's Fund's 2012 review of leadership and engagement. View Details
Keywords: Health Care; Service Quality; Quality; Leadership; Service Delivery; Health Care and Treatment; Health Industry
Citation
Read Now
Related
Bohmer, Richard. "The Instrumental Value of Medical Leadership: Engaging Doctors in Improving Services." King's Fund, London, England, May 2012.
  • 13 Dec 2006
  • Research & Ideas

Improving Public Health for the Poor

healthcare. As a joint endeavor, Project Antares was born from conversations between Chu, the School of Public Health's Barry Bloom, who is dean of the faculty, and David Bloom (not related), a professor of population View Details
Keywords: by Martha Lagace; Health
  • September 2019
  • Technical Note

Care Economy in the U.S. (Primer)

By: Joseph B. Fuller, William R. Kerr, Manjari Raman and Carl Kreitzberg
This case describes how caregiving responsibilities influence American employees, firms, and the broader economy. It details how sociodemographic trends in the late 20th century transformed the way that Americans balance their personal and professional lives, analyzing... View Details
Keywords: Human Resources; Talent and Talent Management; Demographics; Labor; Health Care and Treatment; Family and Family Relationships; Strategy; Management; United States
Citation
Educators
Purchase
Related
Fuller, Joseph B., William R. Kerr, Manjari Raman, and Carl Kreitzberg. "Care Economy in the U.S. (Primer)." Harvard Business School Technical Note 820-027, September 2019.
  • 07 Mar 2018
  • Research & Ideas

Electronic Health Records Were Supposed to Cut Medical Costs. They Haven't.

$215 depending on the type of visit. That’s despite the fact that Duke has an established electronic health record (EHR) system and an efficient, centralized billing department, Kaplan says. Administrative... View Details
Keywords: by Roberta Holland; Health
  • October 20, 2021
  • Other Article

On the Brink of a Digital Health Care Transformation: What Germany Can Learn from the United States

By: Yoni Goldwasser, William J. Gordon, Jan B. Brönneke and Ariel D. Stern
Citation
Read Now
Related
Goldwasser, Yoni, William J. Gordon, Jan B. Brönneke, and Ariel D. Stern. "On the Brink of a Digital Health Care Transformation: What Germany Can Learn from the United States." Health Affairs Blog (October 20, 2021).
  • August 2022 (Revised January 2023)
  • Case

Icario Health: AI to Drive Health Engagement

By: David C. Edelman
Icario Health has built a market-leading artificial intelligence (AI) engine to help health insurers drive better health behaviors for their members, enabling the insurers to improve their Medicare performance. View Details
Keywords: Marketing; Health Care and Treatment; AI and Machine Learning; Health Industry; United States
Citation
Educators
Purchase
Related
Edelman, David C. "Icario Health: AI to Drive Health Engagement." Harvard Business School Case 523-025, August 2022. (Revised January 2023.)
  • March 2014
  • Editorial

Limits on Use of Health Economic Assessments for Rare Diseases

By: Hanna I. Hyry, Ariel Dora Stern, Jonathan CP Roos and Timothy M. Cox
Funding of expensive treatments for rare ('orphan') diseases is contentious. These agents fare poorly on 'efficiency' or health economic measures, such as the QALY, because of high cost and frequently poor gains in quality of life and survival. We show that... View Details
Keywords: Cost; Health Disorders; Health Care and Treatment; Pharmaceutical Industry
Citation
Find at Harvard
Related
Hyry, Hanna I., Ariel Dora Stern, Jonathan CP Roos, and Timothy M. Cox. "Limits on Use of Health Economic Assessments for Rare Diseases." hcu016. QJM: An International Journal of Medicine 107, no. 3 (March 2014): 241–245.
  • August 1997
  • Article

Preventable Adverse Drug Events in Hospitalized Patients: A Comparative Study of Intensive Care and General Care Units

By: D. J. Cullen, J. Sweitzer, D. W. Bates, E. Burdick, A. Edmondson and L. L. Leape
Keywords: Health; Information
Citation
Find at Harvard
Related
Cullen, D. J., J. Sweitzer, D. W. Bates, E. Burdick, A. Edmondson, and L. L. Leape. "Preventable Adverse Drug Events in Hospitalized Patients: A Comparative Study of Intensive Care and General Care Units." Critical Care Medicine 25, no. 8 (August 1997): 1289–1297.

    Give Employees Cash to Purchase Their Own Health Insurance

    Employers’ and employees’ health care costs continue to skyrocket. A solution is to allow employers to give employees pre-tax cash to purchase their own health insurance. This move, enabled by a newly enacted federal rule, would put competitive pressure on insurers,... View Details
    • 28 Apr 2016
    • News

    Is good health good for business?

    • Web

    THE VALUE OF THE PHYSICIAN SHADOW PROGRAM: Witnessing The Front Lines of Care Delivery - Blog: Health Supplement

    Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author... View Details
    • March 2021 (Revised January 2022)
    • Case

    Philips: Redefining Telehealth

    By: Regina E. Herzlinger, Alec Petersen, Natalie Kindred and Sara M. McKinley
    As one of the world’s largest healthcare companies, Philips sought to reach beyond the walls of the hospital and expand its hospital-to-home program to gain future competitive advantage through technology solutions combining predictive analytics with care delivery. By... View Details
    Keywords: Health Care; Philips; Visicu; Telemedicine; eICU; Accountable Care Organization; ACO; Bundled Payment; Hospital To Home; Patient Monitoring Devices; Home Health Care; Health Care and Treatment; Communication Technology; Quality; Safety; Performance Productivity; Performance Capacity; Performance Efficiency; Consumer Behavior; Emerging Markets; Health Industry; Health Industry; Netherlands
    Citation
    Educators
    Purchase
    Related
    Herzlinger, Regina E., Alec Petersen, Natalie Kindred, and Sara M. McKinley. "Philips: Redefining Telehealth." Harvard Business School Case 321-135, March 2021. (Revised January 2022.) (As companion reading for this case, see: Regina E. Herzlinger and Charles Huang. "Note on Bundled Payment in Health Care," HBS Background Note 312-032.)
    • February 2014
    • Teaching Note

    Community Health Workers in Zambia: Incentive Design and Management

    By: Nava Ashraf and Kristin Johnson
    Keywords: Developing Countries and Economies; Training; Health Care and Treatment; Compensation and Benefits; Recruitment; Selection and Staffing; Mission and Purpose; Non-Governmental Organizations; Motivation and Incentives; Health Industry; Zambia
    Citation
    Purchase
    Related
    Ashraf, Nava, and Kristin Johnson. "Community Health Workers in Zambia: Incentive Design and Management." Harvard Business School Teaching Note 914-024, February 2014. (Request a courtesy copy.)
    • November 2013 (Revised September 2015)
    • Supplement

    GlaxoSmithKline in China (B)

    By: John A. Quelch and Margaret L. Rodriguez
    In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
    Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
    Citation
    Purchase
    Related
    Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
    • January 2014 (Revised June 2014)
    • Case

    23andMe: Genetic Testing for Consumers (A)

    By: John A. Quelch and Margaret L. Rodriguez
    On November 22, 2013, the direct-to-consumer genetic testing provider, 23andMe, received a letter from the U.S. Food and Drug Administration (FDA) ordering the company to halt the sale and promotion of its genetic testing kit. The FDA stated that the product was... View Details
    Keywords: Public Health; Genome Testing; Health Care; Ancestry; 23andMe; Marketing; Product Launch; Health; Health Care and Treatment; Health Testing and Trials; Genetics; Strategy; Health Industry; United States
    Citation
    Educators
    Purchase
    Related
    Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (A)." Harvard Business School Case 514-086, January 2014. (Revised June 2014.)
    • 2021
    • Working Paper

    The Health Costs of Cost-Sharing

    By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
    We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in... View Details
    Keywords: Cost-sharing; Impact; Health Care and Treatment; Insurance; Health; Consumer Behavior
    Citation
    Read Now
    Related
    Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost-Sharing." NBER Working Paper Series, No. 28439, February 2021.
    • July–September 2020
    • Article

    Innovation Contest: Effect of Perceived Support for Learning on Participation

    By: Olivia Jung, Andrea Blasco and Karim R. Lakhani
    Background: Frontline staff are well positioned to conceive improvement opportunities based on first-hand knowledge of what works and does not work. The innovation contest may be a relevant and useful vehicle to elicit staff ideas. However, the success of the... View Details
    Keywords: Contest; Innovation; Employee Engagement; Organizational Learning; Health Care; Health Care Delivery; Innovation and Invention; Organizations; Learning; Employees; Perception; Health Care and Treatment
    Citation
    Find at Harvard
    Related
    Jung, Olivia, Andrea Blasco, and Karim R. Lakhani. "Innovation Contest: Effect of Perceived Support for Learning on Participation." Health Care Management Review 45, no. 3 (July–September 2020): 255–266.
    • 24 Jun 2016
    • News

    Health insurance mergers put consumers last

    • ←
    • 49
    • 50
    • …
    • 218
    • 219
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.